Rush et al. 2005

The objective of the study was to evaluate whether vagus nerve stimulation could provide clinical benefit for patients with severe depression who had not responded adequately to multiple previous treatments.

The researchers aimed to compare outcomes between patients receiving active vagus nerve stimulation and those receiving treatment as usual.

The study followed patients with treatment-resistant depression who received an implanted vagus nerve stimulation device.

Key elements of the design included patients with severe treatment-resistant depression, device implantation, long-term follow-up of depressive symptoms, and comparison with treatment-as-usual control groups.

Clinical outcomes were assessed using established psychiatric rating scales.

The study reported that patients receiving vagus nerve stimulation showed greater long-term improvement in depressive symptoms compared with those receiving treatment as usual.

Some patients experienced meaningful reductions in depression severity over extended follow-up periods.

An important point in the paper was that improvements often appeared gradually rather than immediately after treatment began.

Researchers proposed several possible mechanisms through which vagus nerve stimulation might influence mood regulation.

These included changes in brainstem activity, modulation of limbic system networks, and effects on neurotransmitter systems involved in emotional processing.

Brain imaging work has also suggested that vagus nerve stimulation may influence networks involving the prefrontal cortex and limbic regions.

The vagus nerve connects the brainstem with multiple organs throughout the body and plays a central role in autonomic regulation.

Because it carries both sensory and regulatory signals, stimulation of this nerve can influence neural circuits involved in emotional and physiological regulation.

This connection is one reason the vagus nerve became an important focus in neuromodulation research.

The Rush et al. study became one of the most influential clinical investigations of vagus nerve stimulation in psychiatry.

It contributed to growing scientific interest in neuromodulation approaches for treatment-resistant depression.

The findings also helped support regulatory approval of implanted vagus nerve stimulation for certain cases of treatment-resistant depression in some jurisdictions.

Following this study, additional research examined both implanted and non-invasive forms of vagus nerve stimulation.

Non-invasive approaches such as transcutaneous auricular vagus nerve stimulation later became an especially active area of investigation.

Researchers have continued exploring how vagal stimulation may influence neural networks involved in mood regulation and emotional processing.

Although the study reported promising results, several limitations were noted.

The study population consisted of patients with severe treatment-resistant depression, meaning the findings may not generalize to all individuals with depression.

Researchers also noted that improvements often occurred gradually and that more work was needed to understand mechanisms, timing, and broader clinical implications.

The Rush et al. paper helped demonstrate that neuromodulation approaches targeting the vagus nerve may influence mood regulation in some patients with treatment-resistant depression.

This work contributed to expanding research on brain stimulation therapies and helped establish vagus nerve stimulation as a serious area of investigation in psychiatric neuroscience.

Today, it remains one of the most important historical clinical references in the implanted VNS literature.